DNase γ Is the Effector Endonuclease for Internucleosomal DNA Fragmentation in Necrosis

Abstract

Apoptosis and necrosis, two major forms of cell death, can be distinguished morphologically and biochemically. Internucleosomal DNA fragmentation (INDF) is a biochemical hallmark of apoptosis, and caspase-activated DNase (CAD), also known as DNA fragmentation factor 40 kDa (DFF40), is one of the major effector endonucleases. DNase γ, a Mg2+/Ca2+-dependent endonuclease, is also known to generate INDF but its role among other apoptosis-associated endonucleases in cell death is unclear. Here we show that (i) INDF occurs even during necrosis in cell lines, primary cells, and in tissues of mice in vivo, and (ii) DNase γ, but not CAD, is the effector endonuclease for INDF in cells undergoing necrosis. These results document a previously unappreciated role for INDF in necrosis and define its molecular basis.

Acrolein, a highly toxic aldehyde generated under oxidative stress in vivo, aggravates the mouse liver damage after acetaminophen overdose

“…DNA damage in the liver sections was assessed by TUNEL. The TUNEL assay was initially developed to determine apoptosis, but recently we reported that even in necrosis TUNEL-positive signals can be detected (9). Actually, we detected TUNEL-positive signals in the central necrotic regions (Fig.…”

Nucleic acid-sensing TLRs: trafficking and regulation

“…Likewise, deficiency of DNase I-like III, another member of the DNase I family, causes an aggressive form of familial SLE [55]. In contrast to DNase I, DNase I-like III has the ability to degrade DNA encapsulated in lipids or in the form of dense chromatin particles [56,57]. Accordingly, DNase I-like III-deficient mice experience an elevated concentration of circulating DNA-containing microparticles and develop autoantibodies to DNA and chromatin, followed by an SLE-like disease [58].…”

Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity

“…However, unlike DNASE1 or its other homologs, DNASE1L3 contains a short, positively charged C-terminal peptide that allows it to digest DNA encapsulated into liposomes (Wilber et al, 2002). In addition, DNASE1L3 is more efficient than DNASE1 in the internucleosomal cleavage of genomic DNA in isolated cell nuclei (Napirei et al, 2005), suggesting that it might digest chromatin within apoptotic or necrotic cells (Mizuta et al, 2013). However, neither the natural form of DNA targeted by DNASE1L3 nor the mechanism whereby DNASE1L3 protects from SLE has been elucidated.…”